Last update 16 Nov 2024

Recombinant protein Covid-20 vaccine(Chinese Academy of Medical Sciences and Peking Union Medical College)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms-
Target
SARS-CoV-2 S protein
Mechanism
SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors)
Therapeutic Areas
Infectious Diseases
Active Indication
Coronavirus Infections
Inactive Indication-
Originator Organization
Institute of Materia MedicaInstitute of Materia Medica
Active Organization
The Shenzhen Institutes of Advanced TechnologyThe Shenzhen Institutes of Advanced TechnologyBaylor College of MedicineBaylor College of MedicineInstitute of Materia MedicaInstitute of Materia Medica
Inactive Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Recombinant protein Covid-20 vaccine(Chinese Academy of Medical Sciences and Peking Union Medical College)
Login to view more data
100 Translational Medicine associated with Recombinant protein Covid-20 vaccine(Chinese Academy of Medical Sciences and Peking Union Medical College)
Login to view more data
100 Patents (Medical) associated with Recombinant protein Covid-20 vaccine(Chinese Academy of Medical Sciences and Peking Union Medical College)
Login to view more data
100 Deals associated with Recombinant protein Covid-20 vaccine(Chinese Academy of Medical Sciences and Peking Union Medical College)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Coronavirus InfectionsPreclinical
US
Baylor College of MedicineBaylor College of Medicine
23 May 2023
Coronavirus InfectionsPreclinical
US
The Shenzhen Institutes of Advanced TechnologyThe Shenzhen Institutes of Advanced Technology
23 May 2023
Coronavirus InfectionsPreclinical
US
Institute of Materia MedicaInstitute of Materia Medica
23 May 2023
Coronavirus InfectionsPreclinical
CN
The Shenzhen Institutes of Advanced TechnologyThe Shenzhen Institutes of Advanced Technology
23 May 2023
Coronavirus InfectionsPreclinical
CN
Institute of Materia MedicaInstitute of Materia Medica
23 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free